News

TGA Updates Weight Loss GLP-1 Injectable Medicines with Rare Eye Disease Warning: What Bondi Patients Need to Know The Therapeutic Goods Administration (TGA) has announced an important class-wide safety update for GLP-1 receptor agonists (GLP-1 RAs) following international reviews of emerging evidence linking these medicines with a very rare eye condition called non-arteritic anterior... READ MORE

New Pathology Testing on the Horizon for Early Alzheimer’s Dementia Diagnosis The evidence has evolved remarkably over the past 3–5 years for early Dementia diagnosis. There is now broad international consensus that plasma phosphorylated tau (pTau), particularly pTau217, is the most accurate blood biomarker currently available for detecting Alzheimer’s disease pathology, although... READ MORE

PMOS and Heart Disease: Why Women Need Early Cardiovascular Screening A major new study has brought renewed attention to an important aspect of women’s health: the potential link between polyendocrine metabolic ovarian syndrome (PMOS) and cardiovascular disease. PMOS is the newer name for the condition historically known as polycystic ovary syndrome (PCOS). While PCOS has traditionally... READ MORE

Accessing ADHD Care in NSW and Bondi: The Challenges, New GP Prescribing Pathways and How Ocean Medical Practice Can Help Although awareness of ADHD has increased substantially across Australia, many patients still face significant barriers to accessing diagnosis and treatment. Long waiting lists, high specialist fees and the need for ongoing prescriptions can make managing ADHD both... READ MORE